Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Ancestim | |
| Synonyms |
|
|
| Definitions |
A hematopoietic growth factor with activity on mature and immature hematopoietic progenitor cells. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1646 |
|
| Accepted_Therapeutic_Use_For |
Peripheral blood progenitor cell mobilizer
|
|
| ALT_DEFINITION |
A substance that causes blood stem cells (cells from which other types of cells develop) to change into different types of blood cells and increases the number and actions of these cells in the blood. It is being studied in the treatment of myelodysplasia. Ancestim is a type of recombinant stem cell growth factor.
|
|
| CAS_Registry |
163545-26-4
|
|
| code |
C1646
|
|
| Contributing_Source |
FDA
|
|
| definition |
A hematopoietic growth factor with activity on mature and immature hematopoietic progenitor cells.
|
|
| FDA_UNII_Code |
PYB4Q6JG41
|
|
| in_subset | ||
| label |
Ancestim
|
|
| Legacy Concept Name |
Recombinant_Human_Methionyl_Stem_Cell_Factor
|
|
| Preferred_Name |
Ancestim
|
|
| prefixIRI |
NCIT:C1646
|
|
| prefLabel |
Ancestim
|
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance
|
|
| UMLS_CUI |
C0538777
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping